Genient technologies and envision biotech inks MoU for collaborative approach in complex laboratory infrastructure development
By Genient
The Memorandum of Understanding (MoU) solidifies a collaborative effort between Genient Technologies and Envision Biotech, marking a pivotal step towards pioneering biosafety level 3 and 4 turnkey laboratories. Genient Technologies, specializing in cutting-edge MedTech and life science solutions, focuses on in-vitro diagnostics, IVF, basic science research, and genomics discovery, empowering healthcare advancements.
Envision Biotech, renowned for its expertise in prefabricated cleanrooms, BSL 3 labs, and integrated molecular biology research facilities, joins forces with Genient. This strategic partnership aims to revolutionize life science research, animal biotechnology, and IVF setups. Vishal Verma, Director of Envision Biotech, leads this endeavor, leveraging the company's 16-year legacy in delivering comprehensive cleanroom solutions.
Through this MoU, Genient and Envision synergize their strengths, promising innovative solutions that drive healthcare forward. The collaboration capitalizes on Genient's technology aggregation and Envision's robust infrastructure, envisioning a future where groundbreaking biosafety labs and cutting-edge life science facilities redefine healthcare standards, fostering enhanced patient outcomes and research breakthroughs.